ZYY (08223) has announced that on March 9, 2026, the company entered into a subscription agreement with subscribers. Under the agreement, the company will allot and issue a total of 86 million subscription shares, representing 20.0% of the company's total issued share capital as of the date of this announcement, and approximately 16.67% of the enlarged issued share capital following the issuance. The subscription price is HK$0.50 per share, which represents a discount of approximately 9.09% compared to the closing price of HK$0.55 per share on the last trading day on the Stock Exchange, and a discount of approximately 19.35% compared to the average closing price of approximately HK$0.62 per share over the last five consecutive trading days preceding the date of the subscription agreement. The gross proceeds from the subscription will be HK$43 million, with net proceeds expected to be approximately HK$42.5 million after deducting related expenses. The board intends to use the net proceeds for the group's working capital, with approximately 20% allocated to cover ongoing administrative and operational expenses, and approximately 80% for purchasing trade goods related to the group's medical equipment and consumables trading business.